Welcome to LookChem.com Sign In|Join Free
  • or
(3-Benzyloxy-4-cyano-isothiazol-5-yl)-carbamic acid phenyl ester is a phenyl ester derivative of isothiazole, a five-membered heterocyclic compound containing sulfur and nitrogen. (3-Benzyloxy-4-cyano-isothiazol-5-yl)-carbamic acid phenyl ester also features a cyano group, which is a functional group consisting of a carbon atom triple-bonded to a nitrogen atom. Its unique structure and chemical properties may make it a potential candidate for applications in organic synthesis and medicinal chemistry.

252004-29-8

Post Buying Request

252004-29-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

252004-29-8 Usage

Uses

Used in Organic Synthesis:
(3-Benzyloxy-4-cyano-isothiazol-5-yl)-carbamic acid phenyl ester is used as a synthetic intermediate for the development of various organic compounds due to its reactive functional groups and unique molecular structure.
Used in Medicinal Chemistry:
(3-Benzyloxy-4-cyano-isothiazol-5-yl)-carbamic acid phenyl ester is used as a potential building block in drug discovery and development, leveraging its isothiazole and phenyl ester moieties to create novel pharmaceutical agents.
Further research and investigation are necessary to fully understand the potential uses and effects of (3-Benzyloxy-4-cyano-isothiazol-5-yl)-carbamic acid phenyl ester in these industries.

Check Digit Verification of cas no

The CAS Registry Mumber 252004-29-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,0,0 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 252004-29:
(8*2)+(7*5)+(6*2)+(5*0)+(4*0)+(3*4)+(2*2)+(1*9)=88
88 % 10 = 8
So 252004-29-8 is a valid CAS Registry Number.

252004-29-8Upstream product

252004-29-8Downstream Products

252004-29-8Relevant academic research and scientific papers

Isothiazole derivatives useful as anticancer agents

-

, (2008/06/13)

The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 252004-29-8